Schubert K., Polte T., Bönisch U., Schader S., Holtappels R., Hildebrandt G., Lehmann J., Simon J.C., Anderegg U., Saalbach A. Thy-1 (CD90) regulates the extravasation of leukocytes during inflammation. Eur. J. Immunol. 41, 2011; 645-656 / Saalbach A, Haustein UF, and Anderegg U. A ligand of human Thy-1 is localized on polymorphonuclear leukocytes and monocytes and mediates the binding to activated Thy-1 positive microvascular endothelial cells and fibroblasts. J. Invest. Dermatol. 2000; 115: 882-888 / Wetzel A., Wetzig T., Haustein U.F., Sticherling M., Anderegg U., Simon J.C., Saalbach A. Increased Neutrophil Adherence in Psoriasis: Role of the Human Endothelial Cell Receptor Thy-1 (CD90). Journal of Investigative Dermatology. 2006; 126: 441–452 / Saalbach A., Arnhold J., Leßig J., Simon J. C., Anderegg U. Human Thy-1 induces secretion of matrixmetalloproteinase-9 and CXCL8 from human neutrophils. Eur. J. Immunol. 2008; 38: 1391–1403 / Schmidt M., Gutknecht D., Simon J.C., Schulz J.N., Eckes B., Anderegg U., Saalbach A. Controlling the Balance of Fibroblast Proliferation and Differentiation: Impact of Thy-1. J Invest Dermatol. 2015; 135(7):1893-902 / Saalbach, A., Wetzig, T., Haustein, U.F., and Anderegg, U. Detection of human soluble Thy-1 in serum by ELISA: fibroblasts and activated endothelial cells are a possible source of soluble Thy-1 in serum. Cell Tiss. Res. 1999; 298: 307-315 / Wetzel A, Chavakis T, Preissner K, Sticherling M, Haustein U-F, Anderegg U, Saalbach A. Human Thy-1 (CD90) on Activated Endothel Cells is a Counterreceptor for the Leucocyte Integrin Mac-1 (CD11b/CD18). The Journal of Immunology 2004; 172: 3850-3859

Schubert K., Polte T., Bönisch U., Schader S., Holtappels R., Hildebrandt G., Lehmann J., Simon J.C., Anderegg U., Saalbach A. Thy-1 (CD90) regulates the extravasation of leukocytes during inflammation. Eur. J. Immunol. 41, 2011; 645-656 / Saalbach A, Haustein UF, and Anderegg U. A ligand of human Thy-1 is localized on polymorphonuclear leukocytes and monocytes and mediates the binding to activated Thy-1 positive microvascular endothelial cells and fibroblasts. J. Invest. Dermatol. 2000; 115: 882-888 / Wetzel A., Wetzig T., Haustein U.F., Sticherling M., Anderegg U., Simon J.C., Saalbach A. Increased Neutrophil Adherence in Psoriasis: Role of the Human Endothelial Cell Receptor Thy-1 (CD90). Journal of Investigative Dermatology. 2006; 126: 441–452 / Saalbach A., Arnhold J., Leßig J., Simon J. C., Anderegg U. Human Thy-1 induces secretion of matrixmetalloproteinase-9 and CXCL8 from human neutrophils. Eur. J. Immunol. 2008; 38: 1391–1403 / Schmidt M., Gutknecht D., Simon J.C., Schulz J.N., Eckes B., Anderegg U., Saalbach A. Controlling the Balance of Fibroblast Proliferation and Differentiation: Impact of Thy-1. J Invest Dermatol. 2015; 135(7):1893-902 / Saalbach, A., Wetzig, T., Haustein, U.F., and Anderegg, U. Detection of human soluble Thy-1 in serum by ELISA: fibroblasts and activated endothelial cells are a possible source of soluble Thy-1 in serum. Cell Tiss. Res. 1999; 298: 307-315 / Wetzel A, Chavakis T, Preissner K, Sticherling M, Haustein U-F, Anderegg U, Saalbach A. Human Thy-1 (CD90) on Activated Endothel Cells is a Counterreceptor for the Leucocyte Integrin Mac-1 (CD11b/CD18). The Journal of Immunology 2004; 172: 3850-3859